Doximity to Release Q4 Earnings Amid Analyst Concerns
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 26 2026
0mins
Should l Buy DOCS?
Source: seekingalpha
Doximity Inc's stock fell by 5.03% as it crossed below the 5-day SMA, reflecting investor caution ahead of its upcoming earnings report.
Doximity is set to announce its Q4 earnings on May 13, with analysts forecasting a 26.3% decline in earnings per share to $0.28. Despite a projected revenue growth of 4.1% year-over-year, concerns about the company's ability to compete amid AI innovations have surfaced, impacting investor sentiment. The lack of upward revisions in EPS estimates over the past three months further highlights the mixed outlook for the company.
The upcoming earnings report is crucial for Doximity, as it will provide insights into its financial health and ability to navigate competitive pressures. Investors are closely monitoring the situation, as the company's historical performance has shown resilience, but current estimates suggest a challenging environment.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DOCS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DOCS
Wall Street analysts forecast DOCS stock price to rise
18 Analyst Rating
14 Buy
4 Hold
0 Sell
Strong Buy
Current: 18.010
Low
25.00
Averages
42.75
High
63.00
Current: 18.010
Low
25.00
Averages
42.75
High
63.00
About DOCS
Doximity, Inc. provides a digital platform for the United States medical professionals. It offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Doximity Reports Record Cash Flow in Q4, Exceeding Guidance
- Strong Financial Performance: Doximity reported $145 million in revenue for Q4 2026, a 5% year-over-year increase, with full-year revenue reaching $645 million, reflecting the company's robust growth potential in the market.
- Record Cash Flow: The company achieved a record $107 million in free cash flow during Q4, marking its first nine-digit free cash flow quarter, indicating significant improvements in operational efficiency and financial health.
- AI Investment Outlook: While minimal AI revenue contribution is expected for fiscal 2027, the company plans to increase spending on AI computing and go-to-market initiatives, demonstrating long-term confidence in AI technology's potential.
- Leadership Changes: The appointment of new CFO Matt Sonefeldt and new President Dr. Steve Zatz signifies a crucial adjustment in the executive team, aimed at driving the commercialization of AI Search and addressing market uncertainties.
See More
Bitcoin-Linked Stocks Rise as Starbucks Gets Upgrade
- Bitcoin-Linked Stocks Rise: Bitcoin rose 2% as the Senate Banking Committee discussed a regulatory framework for cryptocurrencies, with Coinbase shares jumping nearly 9%, indicating growing market confidence that could drive future growth for related companies.
- Starbucks Upgrade: TD Cowen upgraded Starbucks from hold to buy, raising its price target from $106 to $120, with analysts noting multiple positive sales drivers in a strong market backdrop, suggesting improved performance ahead.
- Ford Stock Surge: Ford shares rose 7%, adding to a 13% gain from Wednesday, as Morgan Stanley highlighted its energy storage business and partnership with CATL, projecting a $3 billion incremental revenue opportunity for Ford's Model e segment.
- Applied Materials Earnings Outlook: Applied Materials saw a 2% increase in shares ahead of its fiscal second-quarter results, with analysts expecting earnings of $2.66 per share and revenue of $7.68 billion, reflecting sustained optimism about semiconductor equipment demand.
See More
Doximity Shares Plunge 25% to Lowest Level Since IPO
- Disappointing Guidance: Doximity (DOCS) experienced a ~25% drop in stock price after its Q4 fiscal 2026 guidance failed to meet Wall Street expectations, reaching its lowest level since its 2021 IPO, indicating market concerns over future growth.
- Analyst Downgrade: KeyBanc Capital Markets downgraded Doximity from Overweight to Sector Weight, projecting fiscal 2027 revenue between $664 million and $676 million due to the AI Search product missing the sales peak, highlighting a lack of catalysts and increased downside risk.
- Market Share Challenges: Analyst Scott Schoenhaus noted that Doximity is not gaining market share this year as budget managers prefer cutting-edge AI or low-cost options over its premium offerings, reflecting a more competitive market landscape.
- AI Investment Year: While Doximity is catching up in AI, the anticipated revenue from the AI Search product is not expected until the second half of 2027, putting pressure on the company's growth outlook and indicating insufficient competitiveness in the digital advertising market.
See More
Doximity Shares Drop 24% After Disappointing Q4 Earnings Report
- Disappointing Performance: Doximity's Q4 sales rose by 5% and free cash flow (FCF) increased by 11%, yet the company fell short of Wall Street's earnings expectations, resulting in a 24% drop in share price as of Thursday morning.
- Conservative Future Outlook: Management's full-year revenue growth guidance for 2027 is only 3% to 5%, coupled with a declining adjusted EBITDA margin, indicating significant growth challenges ahead for the company.
- Increased AI Investment: Despite profitability pressures, Doximity is ramping up investments in AI products, which are expected to further impact margins; however, the company is making promising strides in technology adoption.
- Stable Market Position: With 85% of U.S. physicians on its network and partnerships with 20 of the top hospitals and pharmaceutical companies, Doximity's leadership remains intact, although the industry slowdown will still pose challenges.
See More
Key Market Highlights for Today
- Cerebras IPO: Cerebras Systems successfully raised $5.5 billion in its IPO today, focusing on ultra-fast AI chip processing, with OpenAI committing to purchase its computing capacity, indicating strong market demand for efficient AI computing.
- Cisco's Strong Quarter: Cisco reported a blowout quarter with robust data center performance, sending shares up nearly 15% in premarket trading, reflecting massive demand for networking equipment and underscoring the ongoing growth in AI spending, enhancing the investment case for data center stocks.
- Dell Price Target Increase: Citi raised Dell's price target from $235 to $290 ahead of its earnings report, anticipating continued strong performance in the server market; despite rising memory costs, Dell's scale and pricing agility are expected to provide competitive advantages.
- Broadcom Price Target Boost: Wells Fargo increased Broadcom's price target from $430 to $545, significantly raising AI chip revenue forecasts, highlighting the underappreciated potential in its networking segment, which could drive stock price appreciation.
See More
Cisco's Transformation in the AI Era
- Earnings Surge: Cisco (CSCO) saw a 20% pre-market jump, driven by a positive outlook from its business restructuring, with CFO Mark Patterson indicating an expansion of its silicon portfolio to meet data center demands, thereby enhancing its competitive edge in the AI market.
- Job Cuts and Investments: CEO Chuck Robbins announced nearly 4,000 job cuts; however, the company plans to increase investments in AI, aiming to shift resources towards areas with the strongest demand and long-term value creation, ensuring sustainable growth in the future.
- Chinese Market Opportunities: Alibaba (BABA) and JD.com (JD) received U.S. approval to purchase Nvidia's H200 chips, although no deliveries have been made yet, indicating a significant potential revenue opportunity for Nvidia in the Chinese market, which could impact its dominance in the global chip market.
- AI-Driven Growth: Cellebrite DI (CLBT) is expected to report an 18% year-over-year revenue growth, primarily driven by strong demand for AI-driven investigative tools, showcasing the company's robust execution and adaptability in the AI sector.
See More
Doximity Reports Record Cash Flow in Q4, Exceeding Guidance
- Strong Financial Performance: Doximity reported $145 million in revenue for Q4 2026, a 5% year-over-year increase, with full-year revenue reaching $645 million, reflecting the company's robust growth potential in the market.
- Record Cash Flow: The company achieved a record $107 million in free cash flow during Q4, marking its first nine-digit free cash flow quarter, indicating significant improvements in operational efficiency and financial health.
- AI Investment Outlook: While minimal AI revenue contribution is expected for fiscal 2027, the company plans to increase spending on AI computing and go-to-market initiatives, demonstrating long-term confidence in AI technology's potential.
- Leadership Changes: The appointment of new CFO Matt Sonefeldt and new President Dr. Steve Zatz signifies a crucial adjustment in the executive team, aimed at driving the commercialization of AI Search and addressing market uncertainties.
See More
Bitcoin-Linked Stocks Rise as Starbucks Gets Upgrade
- Bitcoin-Linked Stocks Rise: Bitcoin rose 2% as the Senate Banking Committee discussed a regulatory framework for cryptocurrencies, with Coinbase shares jumping nearly 9%, indicating growing market confidence that could drive future growth for related companies.
- Starbucks Upgrade: TD Cowen upgraded Starbucks from hold to buy, raising its price target from $106 to $120, with analysts noting multiple positive sales drivers in a strong market backdrop, suggesting improved performance ahead.
- Ford Stock Surge: Ford shares rose 7%, adding to a 13% gain from Wednesday, as Morgan Stanley highlighted its energy storage business and partnership with CATL, projecting a $3 billion incremental revenue opportunity for Ford's Model e segment.
- Applied Materials Earnings Outlook: Applied Materials saw a 2% increase in shares ahead of its fiscal second-quarter results, with analysts expecting earnings of $2.66 per share and revenue of $7.68 billion, reflecting sustained optimism about semiconductor equipment demand.
See More
Doximity Shares Plunge 25% to Lowest Level Since IPO
- Disappointing Guidance: Doximity (DOCS) experienced a ~25% drop in stock price after its Q4 fiscal 2026 guidance failed to meet Wall Street expectations, reaching its lowest level since its 2021 IPO, indicating market concerns over future growth.
- Analyst Downgrade: KeyBanc Capital Markets downgraded Doximity from Overweight to Sector Weight, projecting fiscal 2027 revenue between $664 million and $676 million due to the AI Search product missing the sales peak, highlighting a lack of catalysts and increased downside risk.
- Market Share Challenges: Analyst Scott Schoenhaus noted that Doximity is not gaining market share this year as budget managers prefer cutting-edge AI or low-cost options over its premium offerings, reflecting a more competitive market landscape.
- AI Investment Year: While Doximity is catching up in AI, the anticipated revenue from the AI Search product is not expected until the second half of 2027, putting pressure on the company's growth outlook and indicating insufficient competitiveness in the digital advertising market.
See More
Doximity Shares Drop 24% After Disappointing Q4 Earnings Report
- Disappointing Performance: Doximity's Q4 sales rose by 5% and free cash flow (FCF) increased by 11%, yet the company fell short of Wall Street's earnings expectations, resulting in a 24% drop in share price as of Thursday morning.
- Conservative Future Outlook: Management's full-year revenue growth guidance for 2027 is only 3% to 5%, coupled with a declining adjusted EBITDA margin, indicating significant growth challenges ahead for the company.
- Increased AI Investment: Despite profitability pressures, Doximity is ramping up investments in AI products, which are expected to further impact margins; however, the company is making promising strides in technology adoption.
- Stable Market Position: With 85% of U.S. physicians on its network and partnerships with 20 of the top hospitals and pharmaceutical companies, Doximity's leadership remains intact, although the industry slowdown will still pose challenges.
See More
Key Market Highlights for Today
- Cerebras IPO: Cerebras Systems successfully raised $5.5 billion in its IPO today, focusing on ultra-fast AI chip processing, with OpenAI committing to purchase its computing capacity, indicating strong market demand for efficient AI computing.
- Cisco's Strong Quarter: Cisco reported a blowout quarter with robust data center performance, sending shares up nearly 15% in premarket trading, reflecting massive demand for networking equipment and underscoring the ongoing growth in AI spending, enhancing the investment case for data center stocks.
- Dell Price Target Increase: Citi raised Dell's price target from $235 to $290 ahead of its earnings report, anticipating continued strong performance in the server market; despite rising memory costs, Dell's scale and pricing agility are expected to provide competitive advantages.
- Broadcom Price Target Boost: Wells Fargo increased Broadcom's price target from $430 to $545, significantly raising AI chip revenue forecasts, highlighting the underappreciated potential in its networking segment, which could drive stock price appreciation.
See More
Cisco's Transformation in the AI Era
- Earnings Surge: Cisco (CSCO) saw a 20% pre-market jump, driven by a positive outlook from its business restructuring, with CFO Mark Patterson indicating an expansion of its silicon portfolio to meet data center demands, thereby enhancing its competitive edge in the AI market.
- Job Cuts and Investments: CEO Chuck Robbins announced nearly 4,000 job cuts; however, the company plans to increase investments in AI, aiming to shift resources towards areas with the strongest demand and long-term value creation, ensuring sustainable growth in the future.
- Chinese Market Opportunities: Alibaba (BABA) and JD.com (JD) received U.S. approval to purchase Nvidia's H200 chips, although no deliveries have been made yet, indicating a significant potential revenue opportunity for Nvidia in the Chinese market, which could impact its dominance in the global chip market.
- AI-Driven Growth: Cellebrite DI (CLBT) is expected to report an 18% year-over-year revenue growth, primarily driven by strong demand for AI-driven investigative tools, showcasing the company's robust execution and adaptability in the AI sector.
See More
